Atlas Trials

A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)

Clinical trial NCT03619850 · RECRUITING

Trial details

NCT number
NCT03619850
Sponsor
AMAG Pharmaceuticals, Inc.
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Kidney Disease; Iron Deficiency Anemia
Start date
2018-08-13
Primary completion
2026-08-31
Enrollment
129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.